The 20th pharmaceutical analysts convention, IDMA-APA PAC 2018, will be organised from May 18 and 19, 2018.  The event will be held at The Club, DN Nagar, Andheri in Mumbai.
 
The theme of the event is ‘Best practices for world class generics'.  The organising committee for the event is JL Sipahimalani, quality management and technical committee IDMA and APA;  SM Mudda, chairman, regulatory affairs committee, IDMA;  Deepnath Roy Chowdhury, national president, IDMA; Dr Milind Joshi, president, global regulatory management, JB Chemicals and Pharmaceuticals; R Raghunandan, Kapil Bhargava, Dr. S Nagarsenkar, Kaushik Desai, Meena Shah, consultant, regulatory affairs, Dr. Gaurav Pathak, Dr. Uday Shetty and Sridharan.
 
Dr S Eswara Reddy, DCGI, will inaugurate the event. The facilitator of the event is Daara Patel, secretary-general, IDMA. The welcome address will be by Deepnath Roy Chowdhury. The significance of the pharma analysts convention  and its journey through two decades will be provided by Sipahimalani.
 
Dr. GN Singh chairman, Indian Pharmacopeia Commission will be the guest of honour. Dr. Madhur Gupta from the WHO is the special guest of honour.  The keynote address will be delivered by Dr Ranjit Sahani, former vice chairman and managing director, Novartis India. On the occasion, a souvenir will be released on APA forum and this will be followed by the presentation of awards.  There is also an exhibition organised for the event.
 
For the technical session, Dr. Joshi will be facilitator along with Meena Shah.  The first session on Best practices in pharma development will have Dr. Anand Krishnan, consultant, SIDVIM Lifesciences who will address on the formulation development. Dr. Aniruddha Vaidya, director, analytical instruments will delve on the best practices in analytical development. Abhijit Kulkarni, senior vice president-CQA, Baxter Pharma will cover on Lifecycle management.
 
The second technical session will cover on best practices in manufacturing operations. These will cover containment and handling of potent products and compounds. Current practices on aseptic manufacturing will be addressed by Mayilvahanan from GSK. Evaluation techniques for containments will be addressed by Sasidharan Menon, subject matter expert, design and evaluation, Controlled Environment for contamination control.
 
The third session is on best practices in laboratory. Dr. PL Sahu, principal scientific officer and head-R&D, Indian Pharmacopoeia Commission will speak on the  challenges in testing primary packaging.  Dr. Mrunal Jaywant from USP India will highlight the challenges in testing primacy packaging from US Pharmacopeia perspective.  Dr. Mangal Nagarsenkar from BNCP will address on Bridging in-vivo and in-vitro  testing.
 The fourth technical session is on best practises in supply chain which will be followed by a  panel discussion too.